Global Oncology Regulatory Affairs Intern (Hybrid)

Johnson & Johnson Services; United States; Remote; USD 13,000 - 25,000; Full time

Benefits offered by this job

Mentor program

Poster presentation opportunity

Job summary

Johnson & Johnson Services is offering an Oncology Global Regulatory Affairs internship as part of the Global Oncology Internship Program. The 12-week role runs May 10 to August 13, 2027, with a hybrid on-site three days per week and remote two days.

You will join a global matrixed team, contribute to regulatory strategies, and present your research at a symposium. The program seeks students currently enrolled in a university program, pursuing biology/regulatory/pharma tracks, and who are

Qualifications

• > Fluent in English, both written and spoken.
• > Able to work in a global matrixed team.
• > Strong interest in oncology drug development and regulatory processes.
• > Must be enrolled in an accredited university program for the duration of the internship.
• > Able to balance multiple projects in a fast-paced environment.

Responsibilities

• Glean understanding of clinical research and drug development incl. GCPs, ICH, and SOPs.
• Attend lecture series to learn the drug development process.
• Participate in department and cross-functional team meetings.
• Shadow key functional roles for learning opportunities.
• Contribute to assigned projects and group activities.
• Prepare and present an abstract/poster at the annual symposium.
• Develop or enhance communications, planning, and organization skills in a global virtual team.

Skills

Fluent in English

Leadership

Team collaboration

Regulatory affairs knowledge

Education

Currently enrolled in a university program

Pursuing Bachelor’s/Master’s in biology/regulatory/health sciences

Tools

Microsoft Office Suite (Outlook, Excel, PowerPoint, Word)

Teams

SharePoint

Job description

Johnson & Johnson Services is offering an Oncology Global Regulatory Affairs internship as part of the Global Oncology Internship Program. The 12-week role runs May 10 to August 13, 2027, with a hybrid on-site three days per week and remote two days.

You will join a global matrixed team, contribute to regulatory strategies, and present your research at a symposium. The program seeks students currently enrolled in a university program, pursuing biology/regulatory/pharma tracks, and who are